Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study

INTRODUCTION: Parkinson’s disease (PD) patients in chronic levodopa treatment may experience motor and non-motor fluctuations, which may affect their quality of life. Safinamide is a new monoamine oxidase B inhibitor, also exerting a non-dopaminergic effect, recently approved as add-on therapy in fl...

Descripción completa

Detalles Bibliográficos
Autores principales: De Micco, Rosa, Satolli, Sara, Siciliano, Mattia, De Mase, Antonio, Giordano, Alfonso, Tedeschi, Gioacchino, Tessitore, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724100/
https://www.ncbi.nlm.nih.gov/pubmed/34031800
http://dx.doi.org/10.1007/s10072-021-05324-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724100/
https://www.ncbi.nlm.nih.gov/pubmed/34031800
http://dx.doi.org/10.1007/s10072-021-05324-w

Ejemplares similares